(Q40904951)

24 September 2017

title

Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer (English)

1 reference

24 September 2017

3

1 reference

24 September 2017

Müllauer L

1

1 reference

24 September 2017

Mosberger I

series ordinal

2

1 reference

24 September 2017

Rudas M

series ordinal

4

1 reference

24 September 2017

Chott A

series ordinal

5

1 reference

24 September 2017

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

190

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

20-30

1 reference

Apoptosis by death factor

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Fas and FasL in the homeostatic regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

A human cell line from a pleural effusion derived from a breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

FAP-1: a protein tyrosine phosphatase that associates with Fas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Inhibition of the alloantibody response by CD95 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200001%29190%3A1%3C20%3A%3AAID-PATH497%3E3.0.CO%3B2-S

10.1002/(SICI)1096-9896(200001)190:1<20::AID-PATH497>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference